22085605

Summary
Title
Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy.
Authors
  • Biancini GB
  • Vanzin CS
  • Rodrigues DB
  • Deon M
  • Ribas GS
  • Barschak AG
  • Manfredini V
  • Netto CB
  • Jardim LB
  • Giugliani R
  • Vargas CR
Source
Biochim Biophys Acta
Publication Date
2012 Feb
PubMed ID
22085605

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024